Evidence-Based Hope: Insights from Recent Duchenne Muscular...

bir ses eklendi Health

2025-12-26 11:12:19 -

Evidence-Based Hope: Insights from Recent Duchenne Muscular Dystrophy Market Research

In the high-stakes arena of rare disease drug development, data is the most valuable asset. Recent investigations into the DMD treatment landscape in 2025 emphasize a shifting paradigm toward "real-world evidence" (RWE). While clinical trials remain the gold standard, the long-term tracking of patients on newly approved gene therapies is providing vital insights into the durability and safety...

0 Yorumlar 0 hisse senetleri 82 Views 0 önizleme